Merging French innovation with U.S. performance
SBM’s biologics platform supports orthopedic reconstruction and bone defect management using synthetic biomaterial technologies designed for modern surgical workflows.
SBM’s biologics offering supports surgeons managing bone defects, filling osteotomy gaps, and addressing orthopedic reconstruction needs with synthetic biomaterial solutions designed for predictable handling and broad procedural versatility.
Bio-1 is positioned as a synthetic tricalcium phosphate platform intended to support bone regeneration while integrating into modern orthopedic workflows across sports medicine, trauma, and reconstructive applications.
The portfolio includes multiple shapes and presentation formats to help surgeons select the most appropriate implant geometry for the defect profile and procedural objective.
For the U.S. market, this page presents SBM’s biologics line as a practical biologic solution set for surgeons and distributor partners seeking a versatile synthetic bone substitute platform.
Synthetic tricalcium phosphate biologic solution designed to support bone void filling and orthopedic reconstruction.
Various implant geometries designed to adapt to different anatomical defects and surgical requirements.
Applicable across sports medicine, trauma surgery, reconstruction, and joint preservation procedures.
Supports surgeon adoption while strengthening distributor biologics portfolios.
Bio-1 represents SBM’s synthetic bone substitute platform built on tricalcium phosphate technology and designed to support bone defect management across orthopedic procedures.
Access the complete Bio-1 brochure for platform overview and product formats.
Download BrochureConnect with SBM USA to learn more about Bio-1 biologics technologies and distribution opportunities.
Contact Our Team